JP2009545593A5 - - Google Patents

Download PDF

Info

Publication number
JP2009545593A5
JP2009545593A5 JP2009522831A JP2009522831A JP2009545593A5 JP 2009545593 A5 JP2009545593 A5 JP 2009545593A5 JP 2009522831 A JP2009522831 A JP 2009522831A JP 2009522831 A JP2009522831 A JP 2009522831A JP 2009545593 A5 JP2009545593 A5 JP 2009545593A5
Authority
JP
Japan
Prior art keywords
paroxetine
pharmaceutical composition
use according
hormonal changes
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009522831A
Other languages
English (en)
Japanese (ja)
Other versions
JP5846717B2 (ja
JP2009545593A (ja
Filing date
Publication date
Priority claimed from US11/499,586 external-priority patent/US20080033050A1/en
Application filed filed Critical
Publication of JP2009545593A publication Critical patent/JP2009545593A/ja
Publication of JP2009545593A5 publication Critical patent/JP2009545593A5/ja
Application granted granted Critical
Publication of JP5846717B2 publication Critical patent/JP5846717B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009522831A 2006-08-04 2007-07-31 パロキセチンによる体温調節機能障害の治療方法 Expired - Fee Related JP5846717B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11/499,586 2006-08-04
US11/499,586 US20080033050A1 (en) 2006-08-04 2006-08-04 Method of treating thermoregulatory disfunction with paroxetine
PCT/US2007/017062 WO2008019010A2 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014021171A Division JP5895009B2 (ja) 2006-08-04 2014-02-06 パロキセチンによる体温調節機能障害の治療方法

Publications (3)

Publication Number Publication Date
JP2009545593A JP2009545593A (ja) 2009-12-24
JP2009545593A5 true JP2009545593A5 (cg-RX-API-DMAC7.html) 2010-09-16
JP5846717B2 JP5846717B2 (ja) 2016-01-20

Family

ID=39030027

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009522831A Expired - Fee Related JP5846717B2 (ja) 2006-08-04 2007-07-31 パロキセチンによる体温調節機能障害の治療方法
JP2014021171A Expired - Fee Related JP5895009B2 (ja) 2006-08-04 2014-02-06 パロキセチンによる体温調節機能障害の治療方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014021171A Expired - Fee Related JP5895009B2 (ja) 2006-08-04 2014-02-06 パロキセチンによる体温調節機能障害の治療方法

Country Status (27)

Country Link
US (7) US20080033050A1 (cg-RX-API-DMAC7.html)
EP (2) EP2719385B1 (cg-RX-API-DMAC7.html)
JP (2) JP5846717B2 (cg-RX-API-DMAC7.html)
KR (3) KR20150132888A (cg-RX-API-DMAC7.html)
CN (1) CN101505759A (cg-RX-API-DMAC7.html)
AU (1) AU2007282065B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0715087A2 (cg-RX-API-DMAC7.html)
CA (1) CA2659577C (cg-RX-API-DMAC7.html)
CY (2) CY1120867T1 (cg-RX-API-DMAC7.html)
DK (2) DK2719385T3 (cg-RX-API-DMAC7.html)
ES (2) ES2698207T3 (cg-RX-API-DMAC7.html)
HR (2) HRP20181893T1 (cg-RX-API-DMAC7.html)
HU (2) HUE040481T2 (cg-RX-API-DMAC7.html)
IL (1) IL196844A (cg-RX-API-DMAC7.html)
LT (2) LT2068881T (cg-RX-API-DMAC7.html)
ME (1) ME00592B (cg-RX-API-DMAC7.html)
MX (1) MX2009001275A (cg-RX-API-DMAC7.html)
NO (1) NO343176B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ574735A (cg-RX-API-DMAC7.html)
PL (2) PL2068881T3 (cg-RX-API-DMAC7.html)
PT (2) PT2719385T (cg-RX-API-DMAC7.html)
RS (2) RS58046B1 (cg-RX-API-DMAC7.html)
RU (1) RU2478379C2 (cg-RX-API-DMAC7.html)
SG (1) SG176452A1 (cg-RX-API-DMAC7.html)
SI (2) SI2719385T1 (cg-RX-API-DMAC7.html)
UA (1) UA96770C2 (cg-RX-API-DMAC7.html)
WO (1) WO2008019010A2 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
SG11201708162UA (en) * 2015-04-07 2017-11-29 Meiji Co Ltd Hot flash-suppressing agent
KR102817311B1 (ko) 2016-09-29 2025-06-09 (주)아모레퍼시픽 젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
DE3688827T2 (de) * 1985-10-25 1994-03-31 Beecham Group Plc Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel.
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
JPH0837567A (ja) 1994-07-26 1996-02-06 Olympus Optical Co Ltd 情報記録媒体及び情報再生装置
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
JP2002514222A (ja) * 1997-05-29 2002-05-14 スミスクライン・ビーチャム・コーポレイション 新規方法
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
BR9908431A (pt) 1998-03-02 2000-10-31 Lilly Co Eli Cloridrato de fluoxetina para diminuição de fogalhos
CA2323896A1 (en) 1998-03-16 1999-09-23 Andrew Simon Craig Crystalline form of paroxetine
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) * 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) * 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
AU2001296084A1 (en) 2000-08-28 2002-03-13 Synthon B.V. Paroxetine compositions and processes for making the same
US6498184B2 (en) * 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
JP2004520333A (ja) * 2001-01-04 2004-07-08 フエルレル インターナショナル,ソシエダッド アノニマ (±)−トランス−4−p−フルオロフェニル−3−ヒドロキシメチル−1−メチルピペリジンの製造方法。
DE20100529U1 (de) 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR20050049476A (ko) * 2002-08-14 2005-05-25 파마시아 앤드 업존 캄파니 엘엘씨 홍조를 치료하기 위한 레복세틴의 용도
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) * 2003-01-03 2006-12-01 Lite On It Corp Method to detect the type of optical disk
US20050130987A1 (en) 2003-10-14 2005-06-16 Wyeth Methods of treating vasomotor symptoms
JP2008507552A (ja) * 2004-07-22 2008-03-13 ワイス 神経系障害および状態の治療方法
JP2008507550A (ja) * 2004-07-22 2008-03-13 ワイス 神経系障害及び状態の処置方法
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Similar Documents

Publication Publication Date Title
JP2009525343A5 (cg-RX-API-DMAC7.html)
ES2393211T3 (es) Uso de 2-aminotetralinas sustituidas para la fabricación de un medicamento para la prevención, alivio y/o tratamiento de diversos tipos de dolor
JP5386173B2 (ja) 閉経前の性的欲求障害の治療のためのフリバンセリンの使用
JP2009541443A5 (cg-RX-API-DMAC7.html)
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
JP2011520981A5 (cg-RX-API-DMAC7.html)
JP2005506370A5 (cg-RX-API-DMAC7.html)
JP2010522137A5 (cg-RX-API-DMAC7.html)
HRP20180942T1 (hr) Liječenje negativnih simptoma shizofrenije s (r)-7-kloro-n-(kinuklidin-3-il)benzo[b]tiofen-2-karboksamidom i njegovim farmaceutski prihvatljivim solima
JP2016185995A5 (cg-RX-API-DMAC7.html)
JP2010536849A5 (cg-RX-API-DMAC7.html)
JP2005512995A5 (cg-RX-API-DMAC7.html)
Lee et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial
JP2008540672A (ja) 病状に起因する性的機能不全の治療方法
JP2009280621A5 (cg-RX-API-DMAC7.html)
JP2009545593A5 (cg-RX-API-DMAC7.html)
JP2008110970A5 (cg-RX-API-DMAC7.html)
RU2007132725A (ru) Применение неопиатного анальгетика флупиртина для лечения гиперактивности мочевого пузыря и родственных заболеваний, в том числе неотложного недержания мочи, проблем с мочеотделением, как результата гиперплазии предстательной железы и синдрома раздраженного кишечника
Kim et al. Effects of DA‐9701, a novel prokinetic agent, on gastric accommodation in conscious dogs
JP2017526693A5 (cg-RX-API-DMAC7.html)
JP2010539130A5 (cg-RX-API-DMAC7.html)
JP2011500589A5 (cg-RX-API-DMAC7.html)
JP2024010018A (ja) うつ病を治療するための組成物および方法
JP2008516909A5 (cg-RX-API-DMAC7.html)
JP2010024244A5 (cg-RX-API-DMAC7.html)